title: Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
authors.affiliation: Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK mona.bafadhel@ndm.ox.ac.uk.
authors.forename: Mona
authors.initials: M
authors.lastname: Bafadhel
authors.affiliation: Aintree Chest Centre, University Hospital Aintree, Liverpool, UK.
authors.forename: Lisa
authors.initials: L
authors.lastname: Davies
authors.affiliation: Aintree Chest Centre, University Hospital Aintree, Liverpool, UK Institute of Ageing and Chronic Diseases, University of Liverpool, Liverpool, UK.
authors.forename: Peter M A
authors.initials: PM
authors.lastname: Calverley
authors.affiliation: Dept of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada.
authors.forename: Shawn D
authors.initials: SD
authors.lastname: Aaron
authors.affiliation: Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK.
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Brightling
authors.affiliation: Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
authors.forename: Ian D
authors.initials: ID
authors.lastname: Pavord
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000368:Aged; D018450:Disease Progression; D004804:Eosinophils / Q000166:cytology*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012907:Smoking; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D011239:Prednisolone